Evogene Ltd. (EVGN)

NASDAQ: EVGN · IEX Real-Time Price · USD
1.57
0.05 (3.29%)
At close: Jan 14, 2022 4:00 PM
1.59
0.02 (1.27%)
After-hours:Jan 14, 2022 5:51 PM EST
Market Cap64.90M
Revenue (ttm)1.04M
Net Income (ttm)-23.37M
Shares Out41.34M
EPS (ttm)-0.74
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume265,973
Open1.50
Previous Close1.52
Day's Range1.45 - 1.59
52-Week Range1.45 - 10.24
Beta0.84
AnalystsStrong Buy
Price Target11.33 (+621.9%)
Earnings DateNov 17, 2021

About EVGN

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and...

IndustryBiotechnology
Founded1999
Employees131
Stock ExchangeNASDAQ
Ticker SymbolEVGN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for Evogene stock is "Strong Buy." The 12-month stock price forecast is 11.33, which is an increase of 621.87% from the latest price.

Price Target
$11.33
(621.87% upside)
Analyst Consensus: Strong Buy

News

Biomica Announces Clearance for First-in-Human Phase I Study of BMC-128 in Combination with Bristol Myers Squibb's An...

REHOVOT, Israel, Jan. 11, 2022 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.

5 days ago - PRNewsWire

Lavie Bio Reports Advancement in its Bio-Fungicide Program for Fruit Rots

REHOVOT, Israel, Dec. 14, 2021 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introducti...

1 month ago - PRNewsWire

Biomica Reports Positive Results from Pre-Clinical Studies in its Inflammatory Bowel Disease (IBD) Program

REHOVOT, Israel, Nov. 30, 2021 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: E...

1 month ago - PRNewsWire

Evogene Reports Slight YoY Boost In Q3 Revenue, Looks To Turn Subsidiaries Into Public Companies

Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), the parent company of medical cannabis-focused Canonic, reported its financial results Wednesday for the first nine months and third quarter of 2021.

1 month ago - Benzinga

Evogene Reports Third Quarter 2021 Financial Results

REHOVOT, Israel, Nov. 17, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development...

1 month ago - PRNewsWire

Evogene Announces Participation in the Second Research Period of the CRISPR-IL Consortium

REHOVOT, Israel, Nov. 10, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across severa...

2 months ago - PRNewsWire

Lavie Bio Announces Commercial Launch of its First Microbiome-Based Product for Yield Improvement - result™

REHOVOT, Israel, Nov. 3, 2021 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd.

2 months ago - PRNewsWire

Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica's Microbiome-Based Immuno-Oncology Drug

REHOVOT and HAIFA, Israel, Oct. 27, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.

2 months ago - PRNewsWire

Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2021

REHOVOT, Israel, Oct. 27, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several m...

2 months ago - PRNewsWire

Evogene's Canonic Launches First Two Medical Cannabis Products In Israel Ahead Of Schedule

Evogene Ltd.'s (NASDAQ:EVGN) (TASE: EVGN) wholly-owned subsidiary focused on developing medical cannabis products, Canonic Ltd.

2 months ago - Benzinga

Canonic Announces Full Commercial Launch of its First Medical Cannabis Products in Israel

REHOVOT, Israel, Oct. 19, 2021 /PRNewswire/ -- Canonic Ltd., focused on the development of medical cannabis products and a wholly-owned subsidiary of Evogene Ltd.

2 months ago - PRNewsWire

Lavie Bio and United Agronomy Announce Signing of Distribution Agreement for Lavie Bio's Inoculant Product

REHOVOT, Israel and BERTHOLD, N.D., Sept. 29, 2021 /PRNewswire/ -- Lavie Bio Ltd.

3 months ago - PRNewsWire

Evogene to Present at Cantor Virtual Global Healthcare Conference, September 2021

REHOVOT, Israel, Sept. 14, 2021 /PRNewswire/ -- Evogene Ltd.

4 months ago - PRNewsWire

What Makes Evogene (EVGN) a New Buy Stock

Evogene (EVGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

4 months ago - Zacks Investment Research

Evogene to Present at H.C. Wainwright 23rd Annual Global Investment Conference - 2021

REHOVOT, Israel, Sept. 1, 2021 /PRNewswire/ -- Evogene Ltd.

4 months ago - PRNewsWire

Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel

REHOVOT, Israel, Aug. 31, 2021 /PRNewswire/ -- Canonic Ltd, a company focused on the development of medical cannabis products and a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a...

4 months ago - PRNewsWire

Evogene Reports $135.000 In Q2 2021 Revenue, Misses Estimates, EPS Beat Projections By $0.02

Biotechnology company Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) posted its financial results Wednesday for the first half and second quarter of 2021 along with a proclamation from the company's president...

5 months ago - Benzinga

Evogene Reports Second Quarter 2021 Financial Results

REHOVOT, Israel, Aug. 11, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development...

5 months ago - PRNewsWire

Evogene to Present at Jefferies Virtual Industrials Conference, 2021

REHOVOT, Israel, July 29, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several m...

5 months ago - PRNewsWire

Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2021

REHOVOT, Israel, July 28, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several m...

5 months ago - PRNewsWire

Best Penny Stocks To Buy Before Marijuana Legalization? 4 To Watch Now

Marijuana legalization is a hot topic & some penny stocks are benefiting in 2021. The post Best Penny Stocks To Buy Before Marijuana Legalization?

Other symbols:EASTOGI
6 months ago - PennyStocks

AgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product Candidate

REHOVOT, Israel, July 6, 2021 /PRNewswire/ -- AgPlenus Ltd., a company designing effective, sustainable crop protection products by leveraging computational biology and chemistry, and a subsidiary of Ev...

6 months ago - PRNewsWire

Evogene Announces Ms. Sarit Firon to become Evogene's Chairperson of the Board

REHOVOT, Israel, June 23, 2021 /PRNewswire/ --Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several ma...

6 months ago - PRNewsWire

Shares of Medical Cannabis-Related Evogene Slightly Up On First Quarter Earnings

Computational biology company Evogene Ltd. (NASDAQ:EVGN) reported Wednesday its first-quarter financial results with revenue of $333,000, compared to $75,000 in the same period of 2020.

7 months ago - Benzinga

Evogene Reports First Quarter 2021 Financial Results

REHOVOT, Israel, May 26, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development ...

7 months ago - PRNewsWire